Caplin Point Laboratories, a prominent pharmaceutical company serving Latin America and Africa, has announced a significant milestone. Its subsidiary, Caplin Steriles, has received final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Levetiracetam in Sodium Chloride Injection. A Breakthrough in Seizure Treatment Levetiracetam in Sodium …